Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Ghysdael

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Immunology|April 18, 2015
Control of CD8 T cell proliferation and terminal differentiation by active STAT5 and CDKN2A/CDKN2BMagali Grange, Marilyn Giordano, Amandine Mas, et al.
Nature Medicine|May 23, 2007
Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemiaHind Medyouf, Hélène Alcalde, Caroline Berthier, et al.
Molecular Cancer Research : MCR|January 14, 2018
Novel Intergenically Spliced Chimera, <i>NFATC3-PLA2G15</i>, Is Associated with Aggressive T-ALL Biology and OutcomeJonathan Bond, Christine Tran Quang, Guillaume Hypolite, et al.
Blood|June 3, 2020
Preclinical efficacy of humanized, non-FcγR-binding anti-CD3 antibodies in T-cell acute lymphoblastic leukemiaChristine Tran Quang, Benedetta Zaniboni, Romain Humeau, et al.
The Journal of Biological Chemistry|September 9, 2005
FLI-1 functionally interacts with PIASxalpha, a member of the PIAS E3 SUMO ligase familyEmile van den Akker, Sabine Ano, Hsiu-Ming Shih, et al.
Molecular and Cellular Biology|December 16, 2005
Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient miceAlexis Dumortier, Robin Jeannet, Peggy Kirstetter, et al.
Plos One|January 30, 2014
Lethal giant larvae 1 tumour suppressor activity is not conserved in models of mammalian T and B cell leukaemiaEdwin D Hawkins, Jane Oliaro, Kelly M Ramsbottom, et al.
The Journal of Clinical Investigation|December 4, 2004
TYK2 is a key regulator of the surveillance of B lymphoid tumorsDagmar Stoiber, Boris Kovacic, Christian Schuster, et al.
Journal of Clinical Medicine|November 26, 2022
Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (<i>BCR::ABL+</i>) Acute Lymphoblastic Leukemia (ALL)Jeannig Berrou, Mélanie Dupont, Hanane Djamai, et al.
Blood|September 11, 2010
Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALLRobin Jeannet, Jérôme Mastio, Alejandra Macias-Garcia, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Immunology|April 18, 2015
Control of CD8 T cell proliferation and terminal differentiation by active STAT5 and CDKN2A/CDKN2BMagali Grange, Marilyn Giordano, Amandine Mas, et al.
Nature Medicine|May 23, 2007
Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemiaHind Medyouf, Hélène Alcalde, Caroline Berthier, et al.
Molecular Cancer Research : MCR|January 14, 2018
Novel Intergenically Spliced Chimera, <i>NFATC3-PLA2G15</i>, Is Associated with Aggressive T-ALL Biology and OutcomeJonathan Bond, Christine Tran Quang, Guillaume Hypolite, et al.
Blood|June 3, 2020
Preclinical efficacy of humanized, non-FcγR-binding anti-CD3 antibodies in T-cell acute lymphoblastic leukemiaChristine Tran Quang, Benedetta Zaniboni, Romain Humeau, et al.
The Journal of Biological Chemistry|September 9, 2005
FLI-1 functionally interacts with PIASxalpha, a member of the PIAS E3 SUMO ligase familyEmile van den Akker, Sabine Ano, Hsiu-Ming Shih, et al.
Molecular and Cellular Biology|December 16, 2005
Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient miceAlexis Dumortier, Robin Jeannet, Peggy Kirstetter, et al.
Plos One|January 30, 2014
Lethal giant larvae 1 tumour suppressor activity is not conserved in models of mammalian T and B cell leukaemiaEdwin D Hawkins, Jane Oliaro, Kelly M Ramsbottom, et al.
The Journal of Clinical Investigation|December 4, 2004
TYK2 is a key regulator of the surveillance of B lymphoid tumorsDagmar Stoiber, Boris Kovacic, Christian Schuster, et al.
Journal of Clinical Medicine|November 26, 2022
Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (<i>BCR::ABL+</i>) Acute Lymphoblastic Leukemia (ALL)Jeannig Berrou, Mélanie Dupont, Hanane Djamai, et al.
Blood|September 11, 2010
Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALLRobin Jeannet, Jérôme Mastio, Alejandra Macias-Garcia, et al.
Pageof 4